CYTK

Cytokinetics, Incorporated News Headlines

$6.14
*  
0.27
4.6%
Get CYTK Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More
12/26/2014 4:00:00 PM - Seeking Alpha


Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape
12/26/2014 9:50:07 AM - Zacks.com


Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog
12/24/2014 5:10:00 PM - Zacks.com


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Investopedia


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Zacks.com


Cytokinetics, Incorporated (CYTK) Rises: Stock Jumps 12.6% - Tale of the Tape
12/24/2014 9:32:00 AM - Zacks.com


Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog
12/24/2014 5:10:00 AM - Investopedia


Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
12/23/2014 2:30:00 PM - Investopedia


Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
12/23/2014 2:30:00 PM - Zacks.com


Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog
12/23/2014 2:02:00 PM - Investopedia


Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog
12/23/2014 2:02:00 PM - Zacks.com


Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
12/19/2014 11:20:00 AM - Investopedia


Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
12/19/2014 11:20:00 AM - Zacks.com


Amgen Successfully Expands Xgeva Label in the U.S. - Analyst Blog
12/9/2014 5:00:00 PM - Zacks.com


Health Care Sector Update for 12/05/2014: CYTK,ATOS,PBMD
12/5/2014 3:46:39 PM - MT Newswires


Synageva Completes BLA Submission for Sebelipase Alfa - Analyst Blog
12/4/2014 3:10:00 PM - Zacks.com


Vertex Pharmaceuticals' 52-Week High Driven by Kalydeco - Analyst Blog
12/1/2014 5:00:00 PM - Zacks.com


Can the Rally in Cytokinetics (CYTK) Shares Continue? - Tale of the Tape
11/28/2014 6:38:09 AM - Zacks.com


Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog
11/27/2014 11:50:00 AM - Zacks.com


Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog
11/25/2014 1:20:00 PM - Zacks.com


Epizyme Gains on Positive Phase I Data on EPZ-6438 - Analyst Blog
11/21/2014 6:15:00 PM - Zacks.com


3 Stocks to Buy With Your Bull Market Profits
11/13/2014 10:25:34 AM - InvestorPlace Media


Dynavax's Heplisav Phase III Trial Recommended to Continue - Analyst Blog
11/11/2014 5:30:00 PM - Zacks.com


Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog
11/11/2014 9:00:00 AM - Zacks.com


Intercept Pharmaceuticals' Shares Crash on FLINT Results - Analyst Blog
11/10/2014 5:03:00 PM - Zacks.com